Phillip Foreman

Phillip Foreman

Plus aucun poste en cours

Health Technology
Process Industries
Health Services

Profil

Phillip Foreman has been a Director of TheraBiogen, Inc. since August 31, 2008.
Dr. Forman was appointed as Medical Director of the New York Hyperbaric in 2001.
From July 2005 to January 18, 2007, he served as Chief Executive Officer of American Hyperbaric, Inc. Previously, Dr. Forman was a Principal at Merck & Co., Inc., Pharmacia, OrthoBiotech, Novartis/Organogenesis, Johnson & Johnson, Monsanto, Ortho-McNiel, Alpha Therapeutics, and Ortec International.
He was a Principal at Staten Island University Hospital and Associate and a Director of Residency Program for Staten Island University Hospital.
Dr. Forman has extensive experience in wound care.
He received a degree from the American Board of Podiatric Surgery and a PhD in Podiatric Medicine from the Pennsylvania College of Podiatric Medicine.

Anciens postes connus de Phillip Foreman

SociétésPosteFin
Directeur/Membre du Conseil 07/01/2010
American Hyperbaric, Inc. President 18/01/2007
Corporate Officer/Principal -
Corporate Officer/Principal -
Alpha Therapeutics Corp. Corporate Officer/Principal -
Voir l'expérience en détail de Phillip Foreman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Phillip Foreman

Relations

7

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Health Technology

Process Industries

Health Services

Health Technology

Process Industries

American Hyperbaric, Inc.

Health Services

Consumer Non-Durables

New York Hyperbaric

Alpha Therapeutics Corp.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Phillip Foreman